Abstract
Avian H5N1 influenza viruses first emerged as members of a new human influenza A subtype in Hong Kong in 1997 and there are continuing concerns that members of the subtype will be the cause of the next pandemic. Human-tohuman transmission is rare, but mortality rates associated with avian-to-human transmission are significantly higher than for current human epidemic strains. Severe human H5N1 infections are associated with severe viral pneumonia, diffuse alveolar damage and reactive hemophagocytic syndrome (RHS). A characteristic of RHS, and one of the key determinants of H5N1-mediated pathology, is dysfunctional cytokine production resulting in a cytokine storm. Factors contributing to cytokine dysregulation include viral load, apoptosis and the intrinsic properties of H5N1 virus strains. Here, we review the cytokine response to influenza and try to address the relationship between hypercytokinemia and severe H5N1 pathology.
Keywords: Pathogenic, H5N1, cytokine, storm, reactive, hematophagocytic, syndrome
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Volume: 7 Issue: 2
Author(s): Mark D. Wareing and Gregory A. Tannock
Affiliation:
Keywords: Pathogenic, H5N1, cytokine, storm, reactive, hematophagocytic, syndrome
Abstract: Avian H5N1 influenza viruses first emerged as members of a new human influenza A subtype in Hong Kong in 1997 and there are continuing concerns that members of the subtype will be the cause of the next pandemic. Human-tohuman transmission is rare, but mortality rates associated with avian-to-human transmission are significantly higher than for current human epidemic strains. Severe human H5N1 infections are associated with severe viral pneumonia, diffuse alveolar damage and reactive hemophagocytic syndrome (RHS). A characteristic of RHS, and one of the key determinants of H5N1-mediated pathology, is dysfunctional cytokine production resulting in a cytokine storm. Factors contributing to cytokine dysregulation include viral load, apoptosis and the intrinsic properties of H5N1 virus strains. Here, we review the cytokine response to influenza and try to address the relationship between hypercytokinemia and severe H5N1 pathology.
Export Options
About this article
Cite this article as:
Wareing D. Mark and Tannock A. Gregory, The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (2) . https://dx.doi.org/10.2174/187152308784533131
DOI https://dx.doi.org/10.2174/187152308784533131 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chronic HIV-1 Tat and HIV Reduce Rbfox3/NeuN: Evidence for Sex- Related Effects
Current HIV Research Contribution of Spinal Cord Oligodendrocytes to Neuroinflammatory Diseases and Pain
Current Medicinal Chemistry Mechanisms of HIV-1 Tat Neurotoxicity via CDK5 Translocation and Hyper-Activation: Role in HIV-Associated Neurocognitive Disorders
Current HIV Research Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Redox-Driven Events in the Human Immunodeficiency Virus Type 1 (HIV-1) Infection and their Clinical Implications
Current HIV Research Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma
Recent Patents on Anti-Cancer Drug Discovery Galectin-9 in Cancer Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier
Current Pharmaceutical Design Immuno - Functionalized Silver Nanoparticles for Diagnostics, Therapeutics and Protection of Rabies Viral Infection
Current Nanomedicine Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews Electroporation Advances in Large Animals
Current Gene Therapy Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
Recent Patents on Anti-Infective Drug Discovery Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
CNS & Neurological Disorders - Drug Targets Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Current Neuropharmacology Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Molecular Therapy Intervention Prospects in Prostate Cancer
Current Pharmaceutical Design